April 12, 2022
Ocugen’s phase 2/3 Study of COVAXIN put on hold
FDA has placed on clinical hold Ocugen’s phase 2/3 study for COVAXIN.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Covaxin
Pharmaceuticals, Biotechnology and Life Sciences
FDA has placed on clinical hold Ocugen’s phase 2/3 study for COVAXIN.